Skip to main content

Genetics Startups

Updated August 2026

Companies in the genetics sector developing innovative solutions and technologies.

Explore 329 recently funded genetics companies with verified founder contact information and fundraising data.

Total Companies
329
Total Funding
$1.3B
Avg Funding
$51.6M
Global Reach
5
countries

Top Cities for Genetics

London
Toronto
Stamford
Boston
San Francisco
La Jolla

Recently Funded Companies

Export
London, United Kingdom

Relation Therapeutics is a biotechnology company that focuses on humanizing drug discovery and development.

$26.0M raised
Dec 2025

Founder Contacts

41,000+ verified contacts

Toronto, Canada

Index is a genetic food system traceability solutions provider specializing in source-of-origin traceability and identity preservation.

$250K raised
Jan 2024

Founder Contacts

41,000+ verified contacts

London, United Kingdom

Adendra Therapeutics wants to use new insights into dendritic cell biology to develop a novel type of immunotherapy.

$53.0M raised
Dec 2021

Founder Contacts

41,000+ verified contacts

Stamford, United States

GeneDx uses artificial intelligence and machine learning to analyze patient data to provide insights to transform the practice of medicine.

$150.0M raised
Jan 2023

Founder Contacts

41,000+ verified contacts

Boston, United States

Medici Therapeutics is a biotechnology company that offers gene therapy.

$14.8M raised
Dec 2025

Founder Contacts

41,000+ verified contacts

San Francisco, United States

Denali Therapeutics is dedicated to defeating neurodegenerative diseases to deliver safe and effective medicines to patients and families.

$200.0M raised
Dec 2025

Founder Contacts

41,000+ verified contacts

La Jolla, United States

Kura Oncology, a biopharmaceutical company, advances a pipeline of precision medicines for the treatment of solid tumors and blood cancers.

$150.0M raised
Jan 2024

Founder Contacts

41,000+ verified contacts

Tychy, Poland

IMAGENE.ME is a Białystok-based biotech startup.

$1.5M raised
Dec 2024

Founder Contacts

41,000+ verified contacts

Mountain View, United States

AEENA Dx is developing a saliva-based platform for the detection of cancer and other diseases

$48K raised
Dec 2021

Founder Contacts

41,000+ verified contacts

Wakefield, United States

Myrtelle is a gene therapy company that offers clinical trials for the treatment of rare monogenetic disorders.

$30.5M raised
Dec 2025

Founder Contacts

41,000+ verified contacts

Aurora, United States

RheumaGen develops a class of cell and gene therapy treatments aimed at autoimmune diseases.

Dec 2025

Founder Contacts

41,000+ verified contacts

Gaithersburg, United States

TeraImmune is a developer of cell therapeutics created for autoimmune diseases and immune-related disorders.

$3.0M raised
Dec 2022

Founder Contacts

41,000+ verified contacts

South San Francisco, United States

CODA Biotherapeutics develops a chemogenetic platform designed to modulate neuronal activity.

$28.0M raised
Dec 2021

Founder Contacts

41,000+ verified contacts

Menlo Park, United States

Personalis is a contract research organization and genome-scale diagnostics services company specializing in genome guided medicine.

$50.0M raised
Dec 2024

Founder Contacts

41,000+ verified contacts

Watertown, United States

Syros Pharmaceuticals is a life sciences company that focuses on treating diseases by mapping gene regulatory circuits.

$45.0M raised
Dec 2023

Founder Contacts

41,000+ verified contacts

Burlingame, United States

Protillion Biosciences specializes in the design and development of protein-based drugs.

$18.0M raised
Dec 2022

Founder Contacts

41,000+ verified contacts

Davis, United States

Feanix Biotechnologies is a genetic laboratory for testing samples.

$5.3M raised
Dec 2025

Founder Contacts

41,000+ verified contacts

Beverly Hills, United States

Trethera is a biotechnology company that discovers and develops small molecules that control DNA replication and integrity.

$2.7M raised
Dec 2025

Founder Contacts

41,000+ verified contacts

Edinburgh, United Kingdom

Concinnity Genetics transform the safety of gene therapies by designing novel control mechanisms using AI platform.

$3.8M raised
Dec 2024

Founder Contacts

41,000+ verified contacts

Seattle, United States

ActX is a dynamic venture that focuses on making patient genomic information truly useful in everyday medical practice.

$6.0M raised
Dec 2022

Founder Contacts

41,000+ verified contacts

Courbevoie, France

Depixus are pioneering the development of MAGNA, a novel genetic analysis technology for decoding the dynamic genome.

$34.5M raised
Dec 2021

Founder Contacts

41,000+ verified contacts

South San Francisco, United States

GBT is a clinical-stage biopharmaceutical company developing a therapy for sickle cell disease.

$300.0M raised
Dec 2021

Founder Contacts

41,000+ verified contacts

Palo Alto, United States

Lamar Health helps expensive medications get covered by insurance.

Dec 2024

Founder Contacts

41,000+ verified contacts

Ithaca, United States

Zymtronix develops a patented platform technology that allows innovative and efficient enzyme processes.

$2.0M raised
Dec 2021

Founder Contacts

41,000+ verified contacts

Cranbury, United States

Rocket Pharmaceuticals is a biotech company that develops a pipeline of genetic therapies for rare childhood disorders.

$165.0M raised
Dec 2024

Founder Contacts

41,000+ verified contacts

Showing 251 to 275 of 329 companies

About the Genetics Startup Ecosystem

The genetics sector is an active area of startup innovation and venture capital investment. Companies in this space are developing new technologies, platforms, and services that address evolving market needs and create new business opportunities.

Funding Trends in Genetics

Genetics companies raise capital across various funding stages, from early seed rounds to late-stage growth financing. Investor interest in this sector is driven by the size of the addressable market, the pace of technology adoption, and the potential for scalable business models.

Growth Outlook

The genetics sector is expected to continue evolving as technology advances, market dynamics shift, and new opportunities emerge. Companies that demonstrate strong product-market fit, efficient growth, and clear competitive advantages are well-positioned to attract continued investment.

Genetics Funding Breakdown

Here is how funding is distributed among the 329 genetics companies tracked in the VCBacked database.

Average Funding
$51.6M
Total Funding Tracked
$1.3B
Countries Represented
5

Distribution by Funding Stage

Other25 companies

Top Cities for Genetics

1.London
2 companies$79.0M
2.South San Francisco
2 companies$328.0M
3.Toronto
1 companies$250K
4.Stamford
1 companies$150.0M
5.Boston
1 companies$14.8M

Related Industries

Companies in the genetics sector often overlap with or complement businesses in adjacent industries. Exploring related verticals can help you discover additional companies, identify partnership opportunities, and understand the broader competitive landscape.

Ready to Connect with Genetics Startups?

Perfect for: B2B sales teams targeting genetics companies, investors exploring sector opportunities, and service providers looking for funded companies ready to scale.

Get Started - Access Contact Information

Join thousands of sales teams, investors, and service providers using VCBacked